References
- Ng AP. Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms. Leuk Lymphoma 2013;54:922–933.
- Tefferi A. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012;87:285–293.
- Mirza I, Frantz C, Clarke G, et al. Transformation of polycythemia vera to chronic myelogenous leukemia. Arch Pathol Lab Med 2007; 131:1719–1724.
- Bee PC, Gan GG, Nadarajan VS, et al. A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders. Int J Hematol 2010;91:136–139.
- Kazmi WH, Kausz AT, Khan S, et al. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 2001;38:803–812.
- Eschbach JW, Cook JD, Scribner BH, et al. Iron balance in hemodialysis patients. Ann Intern Med 1977;87:710–713.
- Aguiar RC. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 1998;29:17–26.
- Saviola A, Fiorani C, Ferrara L, et al. Transition of polycythemia vera to chronic myeloid leukaemia. Eur J Haematol 2005;75:264–266.
- Kramer A, Reiter A, Kruth J, et al. JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol 2007;8:658–660.
- Hussein K, Bock O, Seegers A, et al. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Blood 2007;109:4106–4107.